AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32205557 — intervention group
Group type: COMPARATOR
Intervention: No perineorrhaphy
Number of subjects: 46
Study 32173628 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 324
Study 32173628 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 324
Study 33026570 — intervention group
Group type: EXPERIMENTAL
Intervention: Masturbation (at least 3–4 times a week)
Number of subjects: 128
Study 33026570 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 128
Study 33026570 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy alone (Control)
Number of subjects: 128
Study 32390170 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) therapy
Number of subjects: 50
Study 36356631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity care
Number of subjects: 1078
Study 36356631 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1078
Study 34596572 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital human intervention involving cognitive behavioral and positive psychology exercises for at least 15 minutes per day over 1 week.
Number of subjects: 30
Study 34596572 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group that received the intervention 1 week later.
Number of subjects: 30
Study 34596572 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital human intervention
Number of subjects: 30
Study 34596572 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial methods
Number of subjects: 30
Study 35064876 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective titration
Number of subjects: 10
Study 35064876 — intervention group
Group type: EXPERIMENTAL
Intervention: PSG-guided titration using RCMP
Number of subjects: 10
Study 35064876 — intervention group
Group type: EXPERIMENTAL
Intervention: DISE-assisted titration using RCMP
Number of subjects: 10
Study 35064876 — intervention group
Group type: COMPARATOR
Intervention: Control (maximal comfortable protrusion)
Number of subjects: 10
Study 33713213 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (DVR)
Number of subjects: 2334
Study 36416823 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pulse oximetry (every 4 hours)
Number of subjects: 229
Study 36416823 — intervention group
Group type: COMPARATOR
Intervention: Continuous pulse oximetry
Number of subjects: 229
Study 32011942 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Management for Patient‐Centered Targets (IMPaCT)
Number of subjects: 0
Study 36120593 — intervention group
Group type: EXPERIMENTAL
Intervention: OEA 300 mg/day
Number of subjects: 60
Study 36120593 — intervention group
Group type: EXPERIMENTAL
Intervention: OEA 600 mg/day
Number of subjects: 60
Study 36120593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32776357 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 37790
Study 32908282 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-DSS arm (n = 54)
Number of subjects: 108
Study 32908282 — intervention group
Group type: COMPARATOR
Intervention: Physician arm (n = 54)
Number of subjects: 108
Study 34498388 — intervention group
Group type: EXPERIMENTAL
Intervention: BISO/RAMI 10/5 mg
Number of subjects: 64
Study 34498388 — intervention group
Group type: EXPERIMENTAL
Intervention: BISO/RAMI 10/10 mg
Number of subjects: 64
Study 34498388 — intervention group
Group type: COMPARATOR
Intervention: BISO 10 mg and RAMI 10 mg (single doses)
Number of subjects: 64
Study 33928903 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (loading dose 1 g over 10 minutes then infusion of 1 g over 8 hours)
Number of subjects: 9127
Study 33928903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9127
Study 33928903 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 9127
Study 34645170 — intervention group
Group type: EXPERIMENTAL
Intervention: CRS+HIPEC
Number of subjects: 781
Study 32529206 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily fish (∼300 g/wk)
Number of subjects: 199
Study 32529206 — intervention group
Group type: COMPARATOR
Intervention: Poultry (control)
Number of subjects: 199
Study 33808030 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination/reducing diets (Group A, n=50)
Number of subjects: 100
Study 33808030 — intervention group
Group type: COMPARATOR
Intervention: Reducing diets with the same caloric content (Group B, n=50)
Number of subjects: 100
Study 33808030 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination/reducing diets (Group A)
Number of subjects: 100
Study 34717041 — intervention group
Group type: EXPERIMENTAL
Intervention: givosiran (2.5 mg/kg monthly)
Number of subjects: 94
Study 34717041 — intervention group
Group type: COMPARATOR
Intervention: placebo (during double-blind period)
Number of subjects: 94
Study 34023513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOF group)
Number of subjects: 62
Study 34023513 — intervention group
Group type: COMPARATOR
Intervention: Control (CON group)
Number of subjects: 62
Study 33052789 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical scar gel containing Allium cepa extract, allantoin and heparin, applied postoperatively for 6 months.
Number of subjects: 120
Study 33052789 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study 35259918 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy (INV)
Number of subjects: 1819
Study 35259918 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 1819
Study 35259918 — intervention group
Group type: EXPERIMENTAL
Intervention: Both INV and Conservative strategy
Number of subjects: 1819
Study 34693701 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 0
Study 34693701 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 0
Study 34693701 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35292055 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingre Lishi Decoction (QLRD) - 'heat-clearing and diuresis-promoting' prescription
Number of subjects: 78
Study 35292055 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment and colchicine tablets (Control)
Number of subjects: 78
Study 34555158 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT) in the ED
Number of subjects: 474
Study 34555158 — intervention group
Group type: COMPARATOR
Intervention: Central laboratory testing
Number of subjects: 474
Study 32990768 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management
Number of subjects: 0
Study 32990768 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35452654 — intervention group
Group type: EXPERIMENTAL
Intervention: Angle of progression measurement communicated to obstetrician
Number of subjects: 45
Study 35452654 — intervention group
Group type: COMPARATOR
Intervention: Standard digital examination without angle of progression measurement
Number of subjects: 45
Study 34686108 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-coached simulators
Number of subjects: 80
Study 34686108 — intervention group
Group type: EXPERIMENTAL
Intervention: Sophisticated simulators
Number of subjects: 80
Study 34686108 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve simulators
Number of subjects: 80
Study 34686108 — intervention group
Group type: COMPARATOR
Intervention: Honest responding control group
Number of subjects: 80
Study 35501215 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% dextrose solution
Number of subjects: 30
Study 35501215 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 30
Study 32272976 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 648
Study 32272976 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D-3L
Number of subjects: 648
Study 35088613 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Learning Modules Strategy (OLMS)
Number of subjects: 68
Study 35088613 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 34813986 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully Integrated Treatment (FIT) for comorbid SAD and AUD IOP
Number of subjects: 56
Study 34813986 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) consisting of the evidence-based Matrix Model of Addiction IOP
Number of subjects: 56
Study 32188442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfmsp‐2 loci
Number of subjects: 350
Study 32188442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfmsp‐1
Number of subjects: 350
Study 32188442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfmsp‐2
Number of subjects: 350
Study 32188442 — intervention group
Group type: EXPERIMENTAL
Intervention: K1 and MAD20 of Pfmsp1 allelic variant
Number of subjects: 350
Study 33789524 — intervention group
Group type: EXPERIMENTAL
Intervention: H1-receptor antagonists (H1RAs)
Number of subjects: 51
Study 35049172 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Training (RMT)
Number of subjects: 40
Study 35049172 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 40
Study 33091192 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand inhaled interferon beta-1a (AZD9412)
Number of subjects: 121
Study 33091192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 35872235 — intervention group
Group type: EXPERIMENTAL
Intervention: IVPCA (Intravenous Patient-Controlled Analgesia)
Number of subjects: 99
Study 35872235 — intervention group
Group type: COMPARATOR
Intervention: On-demand administration (oral, intramuscular, or intravenous)
Number of subjects: 99
Study 35872235 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study 34006544 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implantation
Number of subjects: 50
Study 34006544 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 50
Study 33657029 — intervention group
Group type: EXPERIMENTAL
Intervention: OT100 online course (n = 74)
Number of subjects: 198
Study 33657029 — intervention group
Group type: EXPERIMENTAL
Intervention: OT100 traditional course (n = 59)
Number of subjects: 198
Study 33657029 — intervention group
Group type: COMPARATOR
Intervention: PT100 control course (n = 65)
Number of subjects: 198
Study 33105390 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR alone
Number of subjects: 30
Study 33105390 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR + EMS
Number of subjects: 30
Study 33105390 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 33105390 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR
Number of subjects: 30
Study 32563290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36345827 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.07% cetylpyridinium chloride (CPC) mouthwash
Number of subjects: 80
Study 36345827 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 80
Study 35679576 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based decision aid combined with standard educational materials
Number of subjects: 282
Study 35679576 — intervention group
Group type: COMPARATOR
Intervention: Standard educational materials alone
Number of subjects: 282
Study 33150559 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal disease (measured by probing pocket depth, PPD)
Number of subjects: 490
Study 33150559 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of teeth with PPD ≥ 4 mm
Number of subjects: 490
Study 32396189 — intervention group
Group type: COMPARATOR
Intervention: SGTF-U
Number of subjects: 332
Study 32396189 — intervention group
Group type: EXPERIMENTAL
Intervention: SGTF-T
Number of subjects: 332
Study 33739913 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyber-ostracized group (n=66)
Number of subjects: 145
Study 33739913 — intervention group
Group type: COMPARATOR
Intervention: Cyber-included group (n=79)
Number of subjects: 145
Study 34183341 — intervention group
Group type: EXPERIMENTAL
Intervention: TRiP(cast) score based thromboprophylactic anticoagulant treatment for patients with a score ≥7
Number of subjects: 0
Study 34183341 — intervention group
Group type: COMPARATOR
Intervention: Current practice of thromboprophylaxis
Number of subjects: 0
Study 33313733 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR CBT‐CP
Number of subjects: 764
Study 33313733 — intervention group
Group type: COMPARATOR
Intervention: Synchronous CBT‐CP
Number of subjects: 764
Study 34392382 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageless robotic-assisted total knee arthroplasty (RATKA)
Number of subjects: 152
Study 34392382 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty (TKA)
Number of subjects: 152
Study 35819423 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenomic-guided treatment (n=966)
Number of subjects: 1944
Study 35819423 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=978)
Number of subjects: 1944
Study 35819423 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenomic-guided treatment
Number of subjects: 1944
Study 35819423 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1944
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: North American sites
Number of subjects: 602
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: International sites
Number of subjects: 602
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sites with research personnel
Number of subjects: 602
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sites without research support
Number of subjects: 602
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: Publicly funded sites
Number of subjects: 602
Study 33743753 — intervention group
Group type: EXPERIMENTAL
Intervention: Privately funded sites
Number of subjects: 602
Study 32802039 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 21
Study 32802039 — intervention group
Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 21
Study 36100350 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label ixekizumab (OL IXE) retreatment after flare
Number of subjects: 155
Study 36100350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 36100350 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ixekizumab treatment
Number of subjects: 155
Study 33899259 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-A (a-BMMSCs + collagen scaffold + aFPL)
Number of subjects: 27
Study 33899259 — intervention group
Group type: COMPARATOR
Intervention: Group-B (collagen scaffold + aFPL without a-BMMSCs)
Number of subjects: 27
Study 33899259 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-C (Minimal Access Flap surgery)
Number of subjects: 27
Study 33899259 — intervention group
Group type: COMPARATOR
Intervention: Group-A and Group-C
Number of subjects: 27
Study 32631400 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (interactive educational video, telecare phone call from a nurse, electronic communication to primary care provider)
Number of subjects: 360
Study 32631400 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-only intervention (interactive educational video only)
Number of subjects: 360
Study 32631400 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 360
Study 32631400 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 360
Study 32631400 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-only intervention
Number of subjects: 360
Study 36126151 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised sprint interval training (SIT) for 12 weeks, 4-6 × 30s cycling bouts, 3 days a week
Number of subjects: 28
Study 36126151 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised sprint interval training (SIT) for 12 weeks
Number of subjects: 28
Study 36126151 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 28
Study 34747132 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathic communication style
Number of subjects: 136
Study 34750069 — intervention group
Group type: COMPARATOR
Intervention: Control group (HT0)
Number of subjects: 24
Study 34750069 — intervention group
Group type: EXPERIMENTAL
Intervention: Once per week heat training (HT1)
Number of subjects: 24
Study 34750069 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice per week heat training (HT2)
Number of subjects: 24
Study 34750069 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat acclimatization and heat acclimation (HAz+HA)
Number of subjects: 24
Study 34750069 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat training (HT)
Number of subjects: 24
Study 34271551 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 100
Study 34271551 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32635999 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimalist footwear (Moleca®)
Number of subjects: 56
Study 32635999 — intervention group
Group type: COMPARATOR
Intervention: Regular clinical treatment for OA
Number of subjects: 56
Study 36232016 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) for 20 minutes, applied to the left dorsolateral prefrontal cortex (F7) with the cathode on the right supraorbital area (Fp2)
Number of subjects: 31
Study 36232016 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 31
Study 34975131 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.75 μg/kg intravenous over 10 min
Number of subjects: 48
Study 34975131 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.035 mg/kg intravenous over 1 min
Number of subjects: 48
Study 34975131 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 48
Study 34975131 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 48
Study 35150184 — intervention group
Group type: EXPERIMENTAL
Intervention: LUMIVIVE® System (LVS) plus basic moisturizer
Number of subjects: 100
Study 35150184 — intervention group
Group type: COMPARATOR
Intervention: basic moisturizer
Number of subjects: 100
Study 32892665 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10000
Study 32892665 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 10000
Study 32836201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2263
Study 35085506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib 400 mg orally once daily and capecitabine 1000 mg/m2 orally twice daily for 14 days, followed by 7 days off every 3 weeks until disease progression or unacceptable toxicity.
Number of subjects: 78
Study 35085506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib plus capecitabine
Number of subjects: 78
Study 33689903 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL): multiple unidirectional FRC-post + dual-cure composite-core
Number of subjects: 60
Study 33689903 — intervention group
Group type: EXPERIMENTAL
Intervention: PFC: multiple unidirectional FRC-post + packable short fiber-reinforced composite (SFRC)
Number of subjects: 60
Study 33689903 — intervention group
Group type: EXPERIMENTAL
Intervention: BPFC: Bioblock technique with only packable SFRC
Number of subjects: 60
Study 33689903 — intervention group
Group type: EXPERIMENTAL
Intervention: BFFC: Bioblock technique with only flowable SFRC
Number of subjects: 60
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Stocking low fat chips next to regular chips
Number of subjects: 0
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Increasing availability of lower energy packs of biscuits
Number of subjects: 0
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Positioning higher fibre breakfast cereals at eye level
Number of subjects: 0
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Price promotion on seasonal fruits and vegetables
Number of subjects: 0
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Nationwide promotion using Disney characters
Number of subjects: 0
Study 35324919 — intervention group
Group type: COMPARATOR
Intervention: Shelf labels to highlight lower sugar beverages
Number of subjects: 0
Study 35722726 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized propensity score matching (GPSM) with stratifying variables
Number of subjects: 0
Study 35722726 — intervention group
Group type: COMPARATOR
Intervention: Non-stratified GPSM
Number of subjects: 0
Study 34756613 — intervention group
Group type: EXPERIMENTAL
Intervention: 2008-2009 seasonal inactivated trivalent influenza vaccine (TIV)
Number of subjects: 3273
Study 34756613 — intervention group
Group type: COMPARATOR
Intervention: Control hepatitis A (HepA) vaccine
Number of subjects: 3273
Study 32915236 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer mentoring intervention (mentees)
Number of subjects: 365
Study 32915236 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 365
Study 32915236 — intervention group
Group type: EXPERIMENTAL
Intervention: Past mentees who became mentors
Number of subjects: 365
Study 35966870 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine (10 mg) with bupivacaine (12.5 mg)
Number of subjects: 86
Study 35966870 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (12.5 mg) alone
Number of subjects: 86
Study 33438085 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (100 mL of orange juice with 12 g carrot and 2.5 g of turmeric) three times per week for three months
Number of subjects: 28
Study 33438085 — intervention group
Group type: COMPARATOR
Intervention: Control group (same juice without turmeric)
Number of subjects: 28
Study 33400078 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental education explaining the rationale behind recommendations to delay fertility treatments due to the COVID‐19 pandemic
Number of subjects: 787